{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:50:11Z","timestamp":1791186611322,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"S6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00415-008-6011-0","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T14:41:07Z","timestamp":1237473667000},"page":"58-65","source":"Crossref","is-referenced-by-count":47,"title":["\u03b14-Integrin antagonism with natalizumab"],"prefix":"10.1007","volume":"255","author":[{"given":"Olaf","family":"St\u00fcve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilhard","family":"Mix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd C.","family":"Kieseier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"7011_CR1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00931808","volume":"75","author":"Anthoons","year":"1989","unstructured":"Anthoons JA, Van Marck EA, GigasePL, Stevens WJ (1989) Immunohistochemicalcharacterization of themononuclear cells in the brain of therat with an experimental chronicTrypanosoma brucei gambiense infection.Parasitol Res 75:251\u2013256","journal-title":"Parasitol Res"},{"key":"7011_CR2","first-page":"532","volume":"84","author":"Becher","year":"2006","unstructured":"Becher B, Bechmann I, Greter M (2006)Antigen presentation in autoimmunityand CNS inflammation: how Tlymphocytes recognize the brain. J MolMed 84:532\u2013543","journal-title":"J MolMed"},{"key":"7011_CR3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ceb.2003.08.003","volume":"15","author":"Carman","year":"2003","unstructured":"Carman CV, Springer TA (2003) Integrinavidity regulation: are changes inaffinity and conformation underemphasized?Curr Opin Cell Biol 15:547\u2013556","journal-title":"Curr Opin Cell Biol"},{"key":"7011_CR4","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.4049\/jimmunol.179.12.8470","volume":"179","author":"Doring","year":"2007","unstructured":"Doring A, Wild M, Vestweber D,Deutsch U, Engelhardt B (2007) E- andP-selectin are not required for thedevelopment of experimental autoimmuneencephalomyelitis in C57BL\/6and SJL mice. J Immunol 179:8470\u20138479","journal-title":"J Immunol"},{"key":"7011_CR5","first-page":"4","volume":"12","author":"Fotheringham","year":"2005","unstructured":"Fotheringham J, Jacobson S (2005)Human herpesvirus 6 and multiplesclerosis: potential mechanisms forvirus-induced disease. Herpes 12:4\u20139","journal-title":"Herpes"},{"key":"7011_CR6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","volume":"354","author":"Frohman","year":"2006","unstructured":"Frohman EM, Racke MK, Raine CS(2006) Multiple sclerosis \u2013 the plaqueand its pathogenesis. N Engl J Med354:942\u2013955","journal-title":"N Engl J Med"},{"key":"7011_CR7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm1197","volume":"11","author":"Greter","year":"2005","unstructured":"Greter M, Heppner FL, Lemos MP,Odermatt BM, Goebels N, Laufer T,Noelle RJ, Becher B (2005) Dendriticcells permit immune invasion of theCNS in an animal model of multiplesclerosis. Nat Med 11:328\u2013334","journal-title":"Nat Med"},{"key":"7011_CR8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1189\/jlb.0303114","volume":"75","author":"Guillemin","year":"2004","unstructured":"Guillemin GJ, Brew BJ (2004) Microglia,macrophages, perivascularmacrophages, and pericytes: a reviewof function and identification. J LeukocBiol 75:388\u2013397","journal-title":"J LeukocBiol"},{"key":"7011_CR9","first-page":"146","volume":"11","author":"Heppner","year":"2005","unstructured":"Heppner FL, Greter M, Marino D,Falsig J, Raivich G, Hovelmeyer N,Waisman A, Rulicke T, Prinz M, PrillerJ, Becher B, Aguzzi A (2005) Experimentalautoimmune encephalomyelitisrepressed by microglial paralysis. NatMed 11:146\u2013152","journal-title":"NatMed"},{"key":"7011_CR10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.3276004","volume":"239","author":"Hickey","year":"1988","unstructured":"Hickey WF, Kimura H (1988) Perivascularmicroglial cells of the CNS arebone marrow-derived and presentantigen in vivo. Science 239:290\u2013292","journal-title":"Science"},{"key":"7011_CR11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.172.4.1025","volume":"172","author":"Huitinga","year":"1990","unstructured":"Huitinga I, van Rooijen N, De Groot CJ,Uitdehaag BM, Dijkstra CD (1990)Suppression of experimental allergicencephalomyelitis in Lewis rats afterelimination of macrophages. J ExpMed 172:1025\u20131033","journal-title":"J ExpMed"},{"key":"7011_CR12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(99)00245-3","volume":"103","author":"Kanwar","year":"2000","unstructured":"Kanwar JR, Harrison JE, Wang D,Leung E, Mueller W, Wagner N, KrissansenGW (2000) Beta7 integrinscontribute to demyelinating disease ofthe central nervous system. J Neuroimmunol103:146\u2013152","journal-title":"J Neuroimmunol"},{"key":"7011_CR13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/brain\/awh156","volume":"127","author":"Kanwar","year":"2004","unstructured":"Kanwar JR, Kanwar RK, KrissansenGW (2004) Simultaneous neuroprotectionand blockade of inflammationreverses autoimmune encephalomyelitis.Brain 127:1313\u20131331","journal-title":"Brain"},{"key":"7011_CR14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1083\/jcb.200404160","volume":"167","author":"Kim","year":"2004","unstructured":"Kim M, Carman CV, Yang W, Salas A,Springer TA (2004) The primacy ofaffinity over clustering in regulation ofadhesiveness of the integrin \u03b1L\u03b22.J Cell Biol 167:1241\u20131253","journal-title":"J Cell Biol"},{"key":"7011_CR15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","volume":"353","author":"Kleinschmidt-Demasters","year":"2005","unstructured":"Kleinschmidt-Demasters BK, Tyler KL(2005) Progressive multifocal leukoencephalopathycomplicating treatmentwith natalizumab and interferonbeta-1a for multiple sclerosis. N Engl JMed 353:369\u2013374","journal-title":"N Engl J Med"},{"key":"7011_CR16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"Langer-Gould","year":"2005","unstructured":"Langer-Gould A, Atlas SW, Green AJ,Bollen AW, Pelletier D (2005) Progressivemultifocal leukoencephalopathy ina patient treated with natalizumab.N Engl J Med 353:375\u2013381","journal-title":"N Engl J Med"},{"key":"7011_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/mic.10.3-4.289.295","volume":"10","author":"Ley","year":"2003","unstructured":"Ley K (2003) Arrest chemokines.Microcirculation 10:289\u2013295","journal-title":"Microcirculation"},{"key":"7011_CR18","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1242\/jcs.113.20.3563","volume":"113","author":"Liu","year":"2000","unstructured":"Liu S, Calderwood DA, Ginsberg MH(2000) Integrin cytoplasmic domainbindingproteins. J Cell Sci 113(Pt 20):3563\u20133571","journal-title":"J Cell Sci"},{"key":"7011_CR19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ni1275","volume":"6","author":"Luster","year":"2005","unstructured":"Luster AD, Alon R, von Andrian UH(2005) Immune cell migration ininflammation: present and futuretherapeutic targets. Nat Immunol6:1182\u20131190","journal-title":"Nat Immunol"},{"key":"7011_CR20","unstructured":"Martin MP, Cravens PD, Winger R,Frohman EM, Racke MK, Eagar TN,Zamvil SS, Weber MS, Hemmer B,Karandikar NJ, Kleinschmidt-DemastersBK, Stuve O (2008) Natalizumabdecreases the numbers of dendriticcells and CD4+ T cells in cerebralperivascular spaces. Arch Neurol 2008Oct 13 (Epub ahead of print)"},{"key":"7011_CR21","first-page":"153","volume":"10","author":"Martin","year":"1992","unstructured":"Martin R, McFarland HF, McFarlin DE(1992) Immunological aspects ofdemyelinating diseases. Annu RevImmunol 10:153\u2013187","journal-title":"Annu RevImmunol"},{"key":"7011_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","volume":"348","author":"Miller","year":"2003","unstructured":"Miller DH, Khan OA, Sheremata WA,Blumhardt LD, Rice GP, Libonati MA,Willmer-Hulme AJ, Dalton CM,Miszkiel KA, O\u2019Connor PW (2003) Acontrolled trial of natalizumab forrelapsing multiple sclerosis. N Engl JMed 348:15\u201323","journal-title":"N Engl JMed"},{"key":"7011_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02648725.1992.10647886","volume":"10","author":"Mountain","year":"1992","unstructured":"Mountain A, Adair JR (1992) Engineeringantibodies for therapy. BiotechnolGenet Eng Rev 10:1\u2013142","journal-title":"BiotechnolGenet Eng Rev"},{"key":"7011_CR24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1074-7613(04)00077-9","volume":"20","author":"Nandi","year":"2004","unstructured":"Nandi A, Estess P, Siegelman M (2004)Bimolecular complex between rollingand firm adhesion receptors requiredfor cell arrest; CD44 association withVLA-4 in T cell extravasation. Immunity20:455\u2013465","journal-title":"Immunity"},{"key":"7011_CR25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1191\/1352458505ms1223oa","volume":"11","author":"Piraino","year":"2005","unstructured":"Piraino PS, Yednock TA, Freedman SB,Messersmith EK, Pleiss MA, Karlik SJ(2005) Suppression of acute experimentalallergic encephalomyelitis witha small molecule inhibitor of alpha4integrin. Mult Scler 11:683\u2013690","journal-title":"Mult Scler"},{"key":"7011_CR26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-5728(02)00273-4","volume":"131","author":"Piraino","year":"2002","unstructured":"Piraino PS, Yednock TA, Freedman SB,Messersmith EK, Pleiss MA, VandevertC, Thorsett ED, Karlik SJ (2002) Prolongedreversal of chronic experimentalallergic encephalomyelitis using asmall molecule inhibitor of alpha4integrin. J Neuroimmunol 131:147\u2013159","journal-title":"J Neuroimmunol"},{"key":"7011_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2005.06.018","volume":"167","author":"Piraino","year":"2005","unstructured":"Piraino PS, Yednock TA, MessersmithEK, Pleiss MA, Freedman SB, HammondRR, Karlik SJ (2005) Spontaneousremyelination following prolongedinhibition of alpha4 integrin in chronicEAE. J Neuroimmunol 167:53\u201363","journal-title":"J Neuroimmunol"},{"key":"7011_CR28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"Polman","year":"2006","unstructured":"Polman CH, O\u2019Connor PW, HavrdovaE, Hutchinson M, Kappos L, Miller DH,Phillips JT, Lublin FD, Giovannoni G,Wajgt A, Toal M, Lynn F, Panzara MA,Sandrock AW (2006) A randomized,placebo-controlled trial of natalizumabfor relapsing multiple sclerosis.N Engl J Med 354:899\u2013910","journal-title":"N Engl J Med"},{"key":"7011_CR29","first-page":"227","volume":"13","author":"Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L,McDonald WI, Davis FA, Ebers GC,Johnson KP, Sibley WA, Silberberg DH,Tourtellotte WW (1983) New diagnosticcriteria for multiple sclerosis:guidelines for research protocols. AnnNeurol 13:227\u2013231","journal-title":"AnnNeurol"},{"key":"7011_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.58.1.39","volume":"58","author":"Rivers","year":"1933","unstructured":"Rivers TM, Sprunt DH, Berry GP(1933) Observations on attempts toproduce acute disseminated encephalomyelitis.J Exp Med 58:39\u201353","journal-title":"J Exp Med"},{"key":"7011_CR31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","volume":"354","author":"Rudick","year":"2006","unstructured":"Rudick RA, Stuart WH, Calabresi PA,Confavreux C, Galetta SL, Radue EW,Lublin FD, Weinstock-Guttman B,Wynn DR, Lynn F, Panzara MA,Sandrock AW (2006) Natalizumab plusinterferon beta-1a for relapsing multiplesclerosis. N Engl J Med 354:911\u2013923","journal-title":"N Engl J Med"},{"key":"7011_CR32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ni1194","volume":"6","author":"Shamri","year":"2005","unstructured":"Shamri R, Grabovsky V, Gauguet JM,Feigelson S, Manevich E, Kolanus W,Robinson MK, Staunton DE, vonAndrian UH, Alon R (2005) Lymphocytearrest requires instantaneousinduction of an extended LFA-1 conformationmediated by endothelium-boundchemokines. Nat Immunol6:497\u2013506","journal-title":"Nat Immunol"},{"key":"7011_CR33","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.52.5.1072","volume":"52","author":"Sheremata","year":"1999","unstructured":"Sheremata WA, Vollmer TL, Stone LA,Willmer-Hulme AJ, Koller M (1999) Asafety and pharmacokinetic study ofintravenous natalizumab in patientswith MS. Neurology 52:1072\u20131074","journal-title":"Neurology"},{"key":"7011_CR34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)81107-1","volume":"85","author":"Steinman","year":"1996","unstructured":"Steinman L (1996) Multiple sclerosis: acoordinated immunological attackagainst myelin in the central nervoussystem. Cell 85:299\u2013302","journal-title":"Cell"},{"key":"7011_CR35","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archneur.63.10.1383","volume":"63","author":"Stuve","year":"2006","unstructured":"Stuve O, Marra CM, Bar-Or A, Niino M,Cravens PD, Cepok S, Frohman EM,Phillips JT, Arendt G, Jerome KR, CookL, Grand\u2019Maison F, Hemmer B,Monson NL, Racke MK (2006) AlteredCD4+\/CD8+ T-cell ratios in cerebrospinalfluid of natalizumab-treatedpatients with multiple sclerosis. ArchNeurol 63:1383\u20131387","journal-title":"Arch Neurol"},{"key":"7011_CR36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.64.2.169","volume":"64","author":"Stuve","year":"2007","unstructured":"Stuve O, Marra CM, Cravens PD, SinghMP, Hu W, Lovett-Racke A, Monson NL,Phillips JT, Cohen Tervaert JW, NashRA, Hartung HP, Kieseier BC, RackeMM, Frohman EM, Hemmer B (2007)Potential risk of progressive multifocalleukoencephalopathy with natalizumabtherapy: possible interventions.Arch Neurol 64:169\u2013176","journal-title":"Arch Neurol"},{"key":"7011_CR37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","volume":"59","author":"Stuve","year":"2006","unstructured":"Stuve O, Marra CM, Jerome KR, Cook L, Cravens PD, Cepok S, Frohman EM,Phillips JT, Arendt G, Hemmer B,Monson NL, Racke MK (2006) Immunesurveillance in multiple sclerosispatients treated with natalizumab.Ann Neurol 59:743\u2013747","journal-title":"Ann Neurol"},{"key":"7011_CR38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0090-1229(95)90130-2","volume":"77","author":"Swanborg","year":"1995","unstructured":"Swanborg RH (1995) Experimentalautoimmune encephalomyelitis inrodents as a model for human demyelinatingdisease. Clin ImmunolImmunopathol 77:4\u201313","journal-title":"Clin ImmunolImmunopathol"},{"key":"7011_CR39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI11717","volume":"107","author":"Theien","year":"2001","unstructured":"Theien BE, Vanderlugt CL, Eagar TN,Nickerson-Nutter C, Nazareno R,Kuchroo VK, Miller SD (2001) Discordanteffects of anti-VLA-4 treatmentbefore and after onset of relapsingexperimental autoimmune encephalomyelitis.J Clin Invest 107:995\u20131006","journal-title":"J Clin Invest"},{"key":"7011_CR40","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood-2003-03-0974","volume":"102","author":"Theien","year":"2003","unstructured":"Theien BE, Vanderlugt CL, Nickerson-Nutter C, Cornebise M, Scott DM,Perper SJ, Whalley ET, Miller SD (2003)Differential effects of treatment with asmall-molecule VLA-4 antagonist beforeand after onset of relapsing EAE.Blood 102:4464\u20134471","journal-title":"Blood"},{"key":"7011_CR41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI12440","volume":"108","author":"Vajkoczy","year":"2001","unstructured":"Vajkoczy P, Laschinger M, EngelhardtB (2001) Alpha4-integrin-VCAM-1binding mediates G protein-independentcapture of encephalitogenic T cellblasts to CNS white matter microvessels.J Clin Invest 108:557\u2013565","journal-title":"J Clin Invest"},{"key":"7011_CR42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","volume":"353","author":"Van Assche","year":"2005","unstructured":"Van Assche G, Van Ranst M, Sciot R,Dubois B, Vermeire S, Noman M,Verbeeck J, Geboes K, Robberecht W,Rutgeerts P (2005) Progressive multifocalleukoencephalopathy after natalizumabtherapy for Crohn\u2019s disease.N Engl J Med 353:362\u2013368","journal-title":"N Engl J Med"},{"key":"7011_CR43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2990.2000.00217.x","volume":"26","author":"Van","year":"2000","unstructured":"Van D, V, De Groot CJ (2000) Staging ofmultiple sclerosis (MS) lesions: pathologyof the time frame of MS. NeuropatholAppl Neurobiol 26:2\u201310","journal-title":"NeuropatholAppl Neurobiol"},{"key":"7011_CR44","doi-asserted-by":"crossref","first-page":"e2028","DOI":"10.1371\/journal.pone.0002028","volume":"3","author":"Yao","year":"2008","unstructured":"Yao K, Gagnon S, Akhyani N, WilliamsE, Fotheringham J, Frohman E, StuveO, Monson N, Racke MK, Jacobson S(2008) Reactivation of human herpesvirus-6 in natalizumab treated multiplesclerosis patients. PLoS ONE3:e2028","journal-title":"PLoS ONE"},{"key":"7011_CR45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","volume":"356","author":"Yednock","year":"1992","unstructured":"Yednock TA, Cannon C, Fritz LC,Sanchez-Madrid F, Steinman L, KarinN (1992) Prevention of experimentalautoimmune encephalomyelitis byantibodies against alpha 4 beta 1integrin. Nature 356:63\u201366","journal-title":"Nature"},{"key":"7011_CR46","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","volume":"354","author":"Yousry","year":"2006","unstructured":"Yousry TA, Major EO, Ryschkewitsch C,Fahle G, Fischer S, Hou J, Curfman B,Miszkiel K, Mueller-Lenke N, SanchezE, Barkhof F, Radue EW, Jager HR,Clifford DB (2006) Evaluation ofpatients treated with natalizumab forprogressive multifocal leukoencephalopathy.N Engl J Med 354:924\u2013933","journal-title":"N Engl J Med"},{"key":"7011_CR47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.iy.08.040190.003051","volume":"8","author":"Zamvil","year":"1990","unstructured":"Zamvil SS, Steinman L (1990) The Tlymphocyte in experimental allergicencephalomyelitis. Annu Rev Immunol8:579\u20136213","journal-title":"Annu Rev Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-6011-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-6011-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-6011-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T12:14:11Z","timestamp":1633263251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-6011-0"}},"subtitle":["Effects and adverse effects"],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":47,"journal-issue":{"issue":"S6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["7011"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-6011-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}